Ming Ann Sim

Ming Ann Sim

Auto-generated profile, based on publicly available information

Ming Ann Sim

National University of Singapore

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 April 2020 in Journal of Bone and Joint Surgery
Verified
Journal Article
Closed access
ZLZhen Chang Liang
Zhen Chang Liang
MCMark Seng Ye Chong
Mark Seng Ye Chong
MSMing Ann Sim
Ming Ann Sim
JLJoel Louis Lim
Joel Louis Lim
PCPablo Castañeda
Pablo Castañeda
JHJames Hoi Po Hui
James Hoi Po Hui

8 June 2018 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MSMing Ann Sim
Ming Ann Sim
WLWeiling Liu
Weiling Liu
SCSophia T H Chew
Sophia T H Chew
LTLian Kah Ti
Lian Kah Ti
Postoperative atrial fibrillation (POAF) is a common complication following cardiac surgery associated with increased morbidity and mortality. Although sustained hyperglycemia is a known risk factor of AF and poor ICU outcomes, emerging in-vitro studies reveal acute glycemic fluctuations to be an additional independent predictor of AF. The effect of acute glycemic fluctuations on the incidence of POAF in the clinical setting remains unclear. We aim to investigate the effect of the magnitude of acute perioperative glycemic fluctuations on the incidence of POAF in a multi-ethnic Southeast-Asian population. We obtained data from1743 patients who underwent elective CABG in a tertiary heart centre from 2009–2011. Patients were kept to a tight baseline glycemic control in accordance with hospital protocol. The magnitude of the difference between the highest and lowest perioperative glucose levels up till the first 48 postoperative hours was employed as a measure of glycemic fluctuation. Patients were divided into 4 groups for analysis based on the magnitude of glycemic fluctuation:A)0-2mmol/L(N = 147); B)>2-4mmol/L(N = 426); C)>4-6mmol/L(N = 513); D)>6mmol/L(N = 657).Our primary outcome was the incidence of POAF. Secondary outcomes included ICU and 30-day mortality and length of stay. The overall incidence of POAF was 14.7%. This increased as the magnitude of glycemic fluctuation increased, and was statistically highest in Group D(16.4%) as compared with the other 3 sub-groups. Multivariate logistic regression revealed the magnitude of perioperative glycemic fluctuation to be an independent risk factor of POAF(O.R.1.06, 95% C.I.1.01–1.11, p = 0.014).ICU length of stay was statistically highest in Group D(63.1 hours, p = < .001). However, ICU and 30 day mortality rates were similar among the 4 groups. Increased magnitudes of acute perioperative glycemic fluctuations are associated with a significantly increased risk of POAF and length of ICU stay; and should therefore be minimised but balanced against the risks of hypoglycemia so as to avoid POAF and optimise patient outcomes.

21 November 2024 in Anesthesia & Analgesia
Verified
Journal Article
Closed access
MSMing Ann Sim
Ming Ann Sim
HWHelen Wilding
Helen Wilding
KAKelly J. Atkins
Kelly J. Atkins
BSBrendan Silbert
Brendan Silbert
DSDavid A. Scott
David A. Scott
LELisbeth Anne Evered
Lisbeth Anne Evered
Preoperative biofluid biomarkers reflecting pathophysiological, neuronal injury, and inflammation as well as those for Alzheimer’s disease (AD) may be valuable tools for the risk stratification of perioperative neurocognitive disorders (PNDs) in older adults. We summarized current evidence relating these preoperative biomarkers to PND beyond 7 days, in older surgical participants aged ≥60 years. Studies that evaluated the association of preoperative biomarkers with cognitive decline as an outcome, beyond 7 days, were identified through searches of 6 databases and 3 trial registries to 17 January 2024. Preclinical studies, intracranial surgical, or studies with participants aged <60 years were excluded. Studies varied widely in the assessment of PND, so a wide range of cognitive outcomes was accepted, including those using the term postoperative cognitive dysfunction (POCD) to define cognitive decline. The pooled incidence of POCD utilizing a binary cognitive outcome was summarized. Fifteen studies involving 2103 participants were included. Marked heterogeneity was evident in the cognitive outcome metrics, assessment timeframes, limiting a quantitative synthesis. Of the 9 studies using binarized cognitive outcomes, the incidence of POCD was 23.4% (95% confidence interval [CI], 6.6–46.2) at <3 months, 11.4% (95% CI, 8.1–15.0) at 3 to <12 months, and 6.9% (95% CI, 1.9–14.5) at ≥12 months postoperatively. Of the 15 studies, 9 described blood-based biomarkers, 4 described cerebrospinal fluid (CSF) biomarkers, and 2 measured both blood and CSF markers. The biomarkers evaluated reflected the pathogenic indicators neuronal injury (9 studies), inflammation (5 studies) and of amyloid (5 studies), and Tau (1 study). The studies included were of medium to high quality. Evidence was the most promising for amyloid biomarkers, with 4 of 5 included studies demonstrating associations of lower preoperative biofluid amyloid biomarker levels with increased risk of POCD. In conclusion, preoperative biofluid amyloid biomarkers may hold potential utility for the prediction of POCD, although current evidence remains limited. Other potential preoperative biomarkers for POCD included p-Tau181 and Neurofilament Light, however small sample sizes, study heterogeneity, and conflicting results limited conclusions drawn. Standardized cognitive outcome metrics and common assessment timeframes are additionally required in future studies to ascertain the prognostic utility of these biomarkers for POCD.

19 November 2024 in Journal of the American Heart Association
Verified
Journal Article
Open access
MSMing Ann Sim
Ming Ann Sim
ETEugene S. J. Tan
Eugene S. J. Tan
SCSiew Pang Chan
Siew Pang Chan
YCYuan Cai
Yuan Cai
YCYuek Ling Chai
Yuek Ling Chai
CCChristopher Chen
Christopher Chen
Background: The association between platelet endothelial cell adhesion molecule‐1 (PECAM‐1) with cerebral small‐vessel disease and cognition in dementia‐free subjects remains uninvestigated. Methods and Results: A prospective cohort of dementia‐free subjects was recruited from memory clinics and followed up for 5 years. Annual neurocognitive assessments and twice‐yearly brain magnetic resonance imaging scans were performed. Associations of baseline plasma PECAM‐1 levels with cerebral small‐vessel disease, cognitive decline (Montreal Cognitive Assessment scores and executive function Z scores), and incident dementia were evaluated. Of 213 subjects (aged 70.2±7.7 years, 51.2% men), median PECAM‐1 levels were 0.790 (interquartile range, 0.645–0.955 ng/mL). Compared with the highest tertile, subjects within the lowest PECAM‐1 tertile had greater cross‐sectional white matter hyperintensity volume (β=4.84 [95% CI, 0.67–9.01]; P =0.023), age‐related white matter change scores (β=1.39 [95% CI, 0.12–2.67]; P =0.033), and cerebral microbleeds (Adjusted risk ratio, 2.59 [95% CI, 1.19–5.62]; P =0.016). Of the 204 participants with follow‐up data (median, 60.0 [interquartile range, 60.0–60.0] months), 24 (11.8%) developed incident dementia. Compared with the highest tertile, subjects within the lower tertiles of PECAM‐1 had a higher risk of incident dementia (first tertile: adjusted hazard ratio [AHR], 4.52 [95% CI, 1.35–15.13]; P =0.024; second tertile: AHR, 3.28 [95% CI, 1.02–10.60]; P =0.047). The lowest PECAM‐1 tertile was associated with greater progression of white matter hyperintensity volume (β=4.15 [95% CI, 0.06–8.24]; P =0.047), cerebral microbleeds (incident relative risk [IRR], 2.21 [95% CI, 1.05–4.65]; P =0.036), and decline in executive function (β=−0.45 [95% CI, −0.76 to −0.14]; P =0.004), and Montreal Cognitive Assessment (β=−1.32 [95% CI, −2.30 to −0.35]; P =0.008) scores. Conclusions: In dementia‐free subjects, lower circulating PECAM‐1 levels are associated with greater cerebral small‐vessel disease progression and cognitive decline, thus warranting future study as a potential therapeutic target.

15 April 2025 in Journal of the American Heart Association
Verified
Journal Article
Open access
ETEugene S. J. Tan
Eugene S. J. Tan
SHSaima Hilal
Saima Hilal
SCSiew Pang Chan
Siew Pang Chan
MSMing Ann Sim
Ming Ann Sim
MLMitchell K.P. Lai
Mitchell K.P. Lai
LLLieng‐Hsi Ling
Lieng‐Hsi Ling
Background: The relationship of left atrial ( LA ) strain with cognition in the absence of atrial fibrillation is poorly understood. We investigated the association of LA strain with cognitive impairment and its pathogenetic subtype (vascular [ VCI ] or neurodegenerative) and underlying mechanisms via associations with circulating and neuroimaging markers of cerebrovascular disease. Methods and Results: LA strain (reservoir, conduit [ LAScd ], contractile) was determined using speckle‐tracking echocardiography in a prospective memory clinic cohort with brain magnetic resonance imaging, neuropsychological assessments, and circulating biomarker measurements. Cognitive impairment was classified as VCI or neurodegenerative in the presence or absence of significant cerebrovascular disease, respectively. Among 251 subjects (age 75±8 years, 59% women) without atrial fibrillation , 178 (71%) had cognitive impairment (20% mild, 14% moderate, 37% dementia); of these impairments, 58% were VCI and 42% neurodegenerative. Only LAScd was associated with more severe cognitive impairment (moderate/dementia versus none/mild, adjusted odds ratio [aOR ] for lowest versus highest tertile >2) and specifically, with worse Mini‐Mental State Examination score and memory on neuropsychological testing. LAScd was independently associated with VCI (versus neurodegenerative; aOR for lowest versus highest tertile, 4.22 [95% CI, 1.59–11.2]) and not with neurodegenerative markers (circulating pTau ‐181 [phosphorylated tau‐181], isolated lobar cerebral microbleeds). Both LAScd and LA reservoir strain were associated with increased burden of cerebral small vessel disease on magnetic resonance imaging, but only LAScd correlated with circulating biomarkers, reflecting inflammation, neurotrophic processes, and neuronal damage. Conclusions: Reduced LA strain was associated with cognitive impairment, primarily of vascular origin, and a higher burden of cerebral small vessel disease. LAScd may be a biomarker of VCI in at‐risk subjects without atrial fibrillation .

21 June 2023 in Journal of Clinical Anesthesia
Verified
Journal Article
Closed access
MSMing Ann Sim
Ming Ann Sim
LSLiang Shen
Liang Shen
LTLian Kah Ti
Lian Kah Ti
BSBan Leong Sng
Ban Leong Sng
BBBirit F.P. Broekman
Birit F.P. Broekman
CBChoon Looi Bong
Choon Looi Bong